Brimonidine tartrate 0.33% gel for the management of posttreatment erythema induced by laser skin resurfacing - Journal of the American Academy of Dermatology
Brimonidine effective but may lead to significant rebound erythema - Journal of the American Academy of Dermatology
Mirvaso (brimonidine): Basics, Side Effects & Reviews
Galderma Announces Availability of Mirvaso® (brimonidine) Topical Gel, 0.33%* | Business Wire
Mirvaso (brimonidine) Topical Gel, 0.33%, 30 g (RX) Ingredients and Reviews